0
May 2, 1959, Vol 170, No. 1 >
ARTICLE | May 2, 1959

PERSISTENCE OF ANTIBODIES AFTER VACCINATION WITH LIVING ATTENUATED POLIOVIRUS

Stanley A. Plotkin, M.D.; George Jervis, M.D.; Thomas Norton, A.B.; Joseph Stokes, M.D.; Hilary Koprowski, M.D.
JAMA. 1959;170(1):8. doi:10.1001/jama.1959.03010010010002.
Text Size: A A A
Published online
Article
References

The duration of immunity produced by oral administration of living attenuated poliovirus has been investigated in three groups of children so treated since 1950. After the administration there was no apparent illness in any of the 26 subjects, but all developed antibodies and the virus was generally demonstrated in the feces. Tests for neutralizing antibodies showed that neither the young age of some of the infants nor their possession of transplacental antibodies had any discernible effect on antibody levels after vaccination and that the seven children in group A (who received the rodent adapted TN type 2 virus) all had type 2 antibody titers ranging from 1:16 to 1:256 approximately eight years after the vaccination. Vaccination with living attenuated poliovirus should theoretically induce lifelong immunity similar to that induced by the natural infection.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Letters

Submit a Letter
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Clear Answers | Save For Later
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs

More Listings at
JAMACareerCenter.com >

© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems